Skip to main content

Incruse Ellipta Dosage

Generic name: UMECLIDINIUM BROMIDE 62.5ug
Dosage form: aerosol, powder
Drug class: Anticholinergic bronchodilators

Medically reviewed by Last updated on Dec 13, 2023.

The recommended dosage of INCRUSE ELLIPTA for maintenance treatment of COPD is 1 actuation (umeclidinium 62.5 mcg) once daily by oral inhalation.

INCRUSE ELLIPTA should be used at the same time every day. Do not use INCRUSE ELLIPTA more than 1 time every 24 hours.
No dosage adjustment is required for geriatric patients, patients with renal impairment, or patients with moderate hepatic impairment [see Clinical Pharmacology (12.3)].

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.